Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Evaluate the Safety and Tolerability of MK0217 in Women
This study has been completed.
Study NCT00092027   Information provided by Merck

First Received on September 21, 2004.   Last Updated on January 21, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Postmenopausal Osteoporosis
Additional conditions recognized in this trial
Osteoporosis
Osteoporosis, Postmenopausal
More general conditions related to this trial
Bone Diseases
Bone Diseases, Metabolic
Musculoskeletal Diseases
Additional drug interventions recognized in this trial
Alendronate
More general drug interventions related to this trial
Bone Density Conservation Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services